ATE142492T1 - Felbamat zur behandlung der lennox-gastaut syndrome - Google Patents

Felbamat zur behandlung der lennox-gastaut syndrome

Info

Publication number
ATE142492T1
ATE142492T1 AT90313735T AT90313735T ATE142492T1 AT E142492 T1 ATE142492 T1 AT E142492T1 AT 90313735 T AT90313735 T AT 90313735T AT 90313735 T AT90313735 T AT 90313735T AT E142492 T1 ATE142492 T1 AT E142492T1
Authority
AT
Austria
Prior art keywords
felbamat
lennox
treatment
gastaut syndrome
gastaut
Prior art date
Application number
AT90313735T
Other languages
English (en)
Inventor
Robert Duane Sofia
Original Assignee
Carter Wallace
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carter Wallace filed Critical Carter Wallace
Application granted granted Critical
Publication of ATE142492T1 publication Critical patent/ATE142492T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Treating Waste Gases (AREA)
  • Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT90313735T 1989-09-26 1990-12-17 Felbamat zur behandlung der lennox-gastaut syndrome ATE142492T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/412,964 US4978680A (en) 1989-09-26 1989-09-26 Method for the prevention and control of epileptic seizure

Publications (1)

Publication Number Publication Date
ATE142492T1 true ATE142492T1 (de) 1996-09-15

Family

ID=23635221

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90313735T ATE142492T1 (de) 1989-09-26 1990-12-17 Felbamat zur behandlung der lennox-gastaut syndrome

Country Status (7)

Country Link
US (1) US4978680A (de)
EP (1) EP0491094B1 (de)
AT (1) ATE142492T1 (de)
DE (1) DE69028542T2 (de)
DK (1) DK0491094T3 (de)
ES (1) ES2094145T3 (de)
GR (1) GR3021801T3 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5055489A (en) * 1990-05-04 1991-10-08 Carter-Wallace, Inc. Method for the prevention and control of hypoxic damage resulting from cerebral ischemic events
DE69219039T2 (de) * 1991-09-03 1997-07-24 Carter Wallace Verwendung von Felbamate zur Herstellung eines Arzneimittels zur Behandlung neuropsychopharmakologischer Störungen
US5290808A (en) * 1992-11-06 1994-03-01 Carter-Wallace, Inc. Method to control the intake of food
US5462966A (en) * 1993-10-15 1995-10-31 Carter-Wallace Inc. Methods for the prevention and control of cellular damage resulting from coronary artery occlusion-reperfusion
US5492930A (en) * 1994-04-25 1996-02-20 Schering Corporation Method and formulation for treating CNS disorders
US5728728A (en) * 1996-04-10 1998-03-17 Kozachuk; Walter E. Methods of providing neuroprotection
US9415222B2 (en) 1998-08-05 2016-08-16 Cyberonics, Inc. Monitoring an epilepsy disease state with a supervisory module
US7231254B2 (en) 1998-08-05 2007-06-12 Bioneuronics Corporation Closed-loop feedback-driven neuromodulation
US7242984B2 (en) 1998-08-05 2007-07-10 Neurovista Corporation Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease
US7277758B2 (en) 1998-08-05 2007-10-02 Neurovista Corporation Methods and systems for predicting future symptomatology in a patient suffering from a neurological or psychiatric disorder
US8762065B2 (en) 1998-08-05 2014-06-24 Cyberonics, Inc. Closed-loop feedback-driven neuromodulation
US9375573B2 (en) 1998-08-05 2016-06-28 Cyberonics, Inc. Systems and methods for monitoring a patient's neurological disease state
US7324851B1 (en) 1998-08-05 2008-01-29 Neurovista Corporation Closed-loop feedback-driven neuromodulation
US7209787B2 (en) 1998-08-05 2007-04-24 Bioneuronics Corporation Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease
US9042988B2 (en) 1998-08-05 2015-05-26 Cyberonics, Inc. Closed-loop vagus nerve stimulation
US7747325B2 (en) 1998-08-05 2010-06-29 Neurovista Corporation Systems and methods for monitoring a patient's neurological disease state
US9113801B2 (en) 1998-08-05 2015-08-25 Cyberonics, Inc. Methods and systems for continuous EEG monitoring
US7403820B2 (en) 1998-08-05 2008-07-22 Neurovista Corporation Closed-loop feedback-driven neuromodulation
ATE244564T1 (de) 1999-02-09 2003-07-15 Univ Virginia Felbamat-derivate
NZ525662A (en) * 2000-10-25 2005-06-24 Univ Virginia Substituted felbamate derived compounds
US20030166648A1 (en) * 2002-11-01 2003-09-04 Macdonald Timothy L Felbamate derived compounds
EP1888570A4 (de) * 2005-04-21 2010-05-19 Medpointe Healthcare Inc Verfahren zur synthese von dicarbamat-verbindungen und zwischenprodukte bei deren formierung
US8868172B2 (en) 2005-12-28 2014-10-21 Cyberonics, Inc. Methods and systems for recommending an appropriate action to a patient for managing epilepsy and other neurological disorders
US8725243B2 (en) 2005-12-28 2014-05-13 Cyberonics, Inc. Methods and systems for recommending an appropriate pharmacological treatment to a patient for managing epilepsy and other neurological disorders
US7676263B2 (en) 2006-06-23 2010-03-09 Neurovista Corporation Minimally invasive system for selecting patient-specific therapy parameters
US8295934B2 (en) 2006-11-14 2012-10-23 Neurovista Corporation Systems and methods of reducing artifact in neurological stimulation systems
WO2008092119A2 (en) 2007-01-25 2008-07-31 Neurovista Corporation Systems and methods for identifying a contra-ictal condition in a subject
WO2008092133A2 (en) * 2007-01-25 2008-07-31 Neurovista Corporation Methods and systems for measuring a subject's susceptibility to a seizure
US8036736B2 (en) 2007-03-21 2011-10-11 Neuro Vista Corporation Implantable systems and methods for identifying a contra-ictal condition in a subject
US9788744B2 (en) 2007-07-27 2017-10-17 Cyberonics, Inc. Systems for monitoring brain activity and patient advisory device
US7884227B2 (en) * 2007-10-26 2011-02-08 Navinta Llc Felbamate with improved bulk density
US9259591B2 (en) 2007-12-28 2016-02-16 Cyberonics, Inc. Housing for an implantable medical device
US20090171168A1 (en) 2007-12-28 2009-07-02 Leyde Kent W Systems and Method for Recording Clinical Manifestations of a Seizure
US8849390B2 (en) 2008-12-29 2014-09-30 Cyberonics, Inc. Processing for multi-channel signals
US8588933B2 (en) 2009-01-09 2013-11-19 Cyberonics, Inc. Medical lead termination sleeve for implantable medical devices
US8786624B2 (en) 2009-06-02 2014-07-22 Cyberonics, Inc. Processing for multi-channel signals
US9643019B2 (en) 2010-02-12 2017-05-09 Cyberonics, Inc. Neurological monitoring and alerts
WO2012032508A1 (en) 2010-09-07 2012-03-15 Taro Pharmaceutical Industries Ltd. Process for the preparation of 2-phenyl-1,3-propanediol

Also Published As

Publication number Publication date
DK0491094T3 (da) 1996-11-11
GR3021801T3 (en) 1997-02-28
EP0491094A1 (de) 1992-06-24
US4978680A (en) 1990-12-18
DE69028542T2 (de) 1997-02-06
EP0491094B1 (de) 1996-09-11
DE69028542D1 (de) 1996-10-17
ES2094145T3 (es) 1997-01-16

Similar Documents

Publication Publication Date Title
DE69028542D1 (de) Felbamat zur Behandlung der Lennox-Gastaut syndrome
ATE143263T1 (de) Behandlung von neurodegenerativen erkrankungen
FI931708A0 (fi) Herbicida substituerade aryl-haloalkylpyrazoler
DE69109560D1 (de) Fungizide Zusammensetzung zur Behandlung von Saatgut.
FI875326A7 (fi) Valonsäteilyttäjälaite korvan lääketieteelliseen hoitoon.
ATE169219T1 (de) Behandlung von katarakt mit 15-keto- prostaglandinderivaten
DE3779053D1 (de)
ATE33098T1 (de) Celiprolol zur behandlung von glaukom.
DE3882642D1 (de) Substituierte tetraline, chromane und verwandte verbindungen fuer die behandlung von asthma, arthritis und verwandte krankheiten.
ATE174221T1 (de) Behandlung von pankreaskrankheit mit 15-keto- prostaglandin e-derivaten
ES508202A0 (es) "procedimiento de tratamiento de vegetales".
ATE137116T1 (de) Behandlung von entzündlichen erkrankungen mit 15- ketoprostaglandinen
DK0662837T3 (da) Anvendelse af IL-10 til forhindring af insulinafhængig diabetes mellitus
ATE132749T1 (de) Behandlung der hepatobilären erkrankung mit 15- ketoprostaglandin-derivaten
IT8121907A0 (it) Dispositivo per lo sterminio di lumache.
NO893710L (no) Fremgangsmaate for behandling av bark for havebruk.
DE3683815D1 (de) Organozinnverbindungen und diese enthaltende pestizide.
DK0430035T3 (da) Anvendelse af benzothiazepiner til fremstilling af lægemidler til behandling af epileptiske anfald
ATE6058T1 (de) Aralkylanilinderivate und herbizide, die diese verbindungen enthalten.
ES2061775T3 (es) Derivados de estrobirulina, su obtencion y empleo.
DK453387A (da) Middel til behandling af arteriosklerose og forhindring af blodpladekoagulation
DE69101948D1 (de) Stabilisierungsbehandlung der katalytischen Aktivität.
IT7823870A0 (it) Impianto per il trattamento dimateriali.
AR245225A1 (es) Composiciones para el tratamiento de cuero.
DE68906028D1 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.

Legal Events

Date Code Title Description
EEFA Change of the company name
EELA Cancelled due to lapse of time